Cargando…
Comparison of Current International Guidelines for the Management of Dyslipidemia
The dyslipidemia guidelines of the three major societies have been revised recently in light of new evidence. LDL-C is the primary target in the ESC, AHA/ACC/Multisociety and Canadian Cardiovascular Society (CCS) guidelines. These guidelines uniformly recommend intensifying lipid-lowering treatment...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737468/ https://www.ncbi.nlm.nih.gov/pubmed/36498823 http://dx.doi.org/10.3390/jcm11237249 |
_version_ | 1784847296669679616 |
---|---|
author | Aygun, Sevda Tokgozoglu, Lale |
author_facet | Aygun, Sevda Tokgozoglu, Lale |
author_sort | Aygun, Sevda |
collection | PubMed |
description | The dyslipidemia guidelines of the three major societies have been revised recently in light of new evidence. LDL-C is the primary target in the ESC, AHA/ACC/Multisociety and Canadian Cardiovascular Society (CCS) guidelines. These guidelines uniformly recommend intensifying lipid-lowering treatment with increased risk; however, the risk estimation systems are different across the guidelines. The ESC guidelines have LDL-C goals which have become more stringent over the years and advocate the use of statin and, if necessary, non-statin therapies to obtain these goals. AHA/ACC/Multisociety guidelines have LDL-C thresholds and advocate combination therapy less liberally and for selected patients. All three guidelines acknowledge the importance of shared decision making. Despite some divergent approaches and recommendations, the main principles and messages are the same across the guidelines. To combat the epidemic of cardiovascular disease, our focus should be not on the differences but on implementing the guidelines in our region. |
format | Online Article Text |
id | pubmed-9737468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97374682022-12-11 Comparison of Current International Guidelines for the Management of Dyslipidemia Aygun, Sevda Tokgozoglu, Lale J Clin Med Review The dyslipidemia guidelines of the three major societies have been revised recently in light of new evidence. LDL-C is the primary target in the ESC, AHA/ACC/Multisociety and Canadian Cardiovascular Society (CCS) guidelines. These guidelines uniformly recommend intensifying lipid-lowering treatment with increased risk; however, the risk estimation systems are different across the guidelines. The ESC guidelines have LDL-C goals which have become more stringent over the years and advocate the use of statin and, if necessary, non-statin therapies to obtain these goals. AHA/ACC/Multisociety guidelines have LDL-C thresholds and advocate combination therapy less liberally and for selected patients. All three guidelines acknowledge the importance of shared decision making. Despite some divergent approaches and recommendations, the main principles and messages are the same across the guidelines. To combat the epidemic of cardiovascular disease, our focus should be not on the differences but on implementing the guidelines in our region. MDPI 2022-12-06 /pmc/articles/PMC9737468/ /pubmed/36498823 http://dx.doi.org/10.3390/jcm11237249 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Aygun, Sevda Tokgozoglu, Lale Comparison of Current International Guidelines for the Management of Dyslipidemia |
title | Comparison of Current International Guidelines for the Management of Dyslipidemia |
title_full | Comparison of Current International Guidelines for the Management of Dyslipidemia |
title_fullStr | Comparison of Current International Guidelines for the Management of Dyslipidemia |
title_full_unstemmed | Comparison of Current International Guidelines for the Management of Dyslipidemia |
title_short | Comparison of Current International Guidelines for the Management of Dyslipidemia |
title_sort | comparison of current international guidelines for the management of dyslipidemia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737468/ https://www.ncbi.nlm.nih.gov/pubmed/36498823 http://dx.doi.org/10.3390/jcm11237249 |
work_keys_str_mv | AT aygunsevda comparisonofcurrentinternationalguidelinesforthemanagementofdyslipidemia AT tokgozoglulale comparisonofcurrentinternationalguidelinesforthemanagementofdyslipidemia |